If you have news to share, comments or suggestions about Findings, we want to hear from you. Send us your news by clicking here.
New Master's Program in Drug Development
Published November 2004
The College of Pharmacy has created a new master's-level degree program specializing in drug development.
The new program will provide cutting-edge training in global aspects of
preclinical and clinical drug development, regulatory affairs,
pharmacovigilance and pharmacoeconomics.
One of only a few master's-level courses of its kind in the country,
the new program will fill a growing need by biopharmaceutical companies
and clinical research organizations (CROs) for employees cross-trained
in scientific and regulatory aspects of drug development.
Fifteen students are enrolled in this new two-year program.
"There's a significant upsurge in global drug discovery and
development," said Daniel Acosta Jr., PhD, dean of the College of
Pharmacy, "fueled by technological advances, shifting paradigms of
pharmaceutical research and evolving regulatory guidelines.
"However, few professionals are educated in the diverse range of
activities needed to take a therapeutic concept from bench top to
bedside. This program will address this unmet and growing need."
College of Pharmacy and other Medical Center faculty members
collaborated with scientists from pharmaceutical and clinical research
companies, including Kendle International Inc., Parexel International,
Patheon Inc., and Procter & Gamble, to perform a marketplace
analysis, make recommendations for the new program and eventually
create a model curriculum and implementation strategy.
Headed by Pankaj B. Desai, PhD, associate professor of
pharmacokinetics, the new program will be supported by 18 UC faculty
members who are internationally known in their specialties.
"As a member of UC's Board of Trustees and the clinical research
industry," said Candace Kendle, PharmD, chairman and CEO of Kendle
International Inc., "I'm confident this groundbreaking program will
provide the world-class educational opportunity we need to help prepare
the next generation of professionals for the pharmaceutical and CRO